Search Results 1431-1440 of 17524 for Absence

  1. A Study Evaluating Tolerability and Efficacy of Navitoclax in Combination With Ruxolitinib in Subjects With Myelofibrosis - Mayo Clinic

    Adequate bone marrow reserves; in the absence of growth factors, thrombopoietic factors, or platelet transfusions for at least 14 days: Platelet count ...

  2. Cervical Spinal Cord Stimulation in Cerebral Vasospasm - Mayo Clinic

    ... absence of vasospasm at the time of initial intervention. Read More on PubMed. Neuromodulation of cerebral blood flow by spinal cord electrical stimulation ...

  3. Study Evaluating Efficacy and Safety of Octagam 10% in Patients With Dermatomyositis (Idiopathic Inflammatory Myopathy) - Mayo Clinic

    Subjects with immune-mediated necrotizing myopathy with absence of typical DM rash. Subjects with generalized, severe musculoskeletal conditions other than ...

  4. Clinical trials - Oncology (Medical)

    Cohort 3 includes (1) CMVpp65 absent and (2) CMVpp65 present GBM.. Patients in all subcohorts except 1.11 and 1.12 currently have unresectable advanced or ...

  5. A Study of Ubenimex in Patients with Pulmonary Arterial Hypertension - Mayo Clinic

    ... absence of left atrial obstruction. Pulmonary vascular resistance (PVR) ≥300 dyn•s/cm5 (3.75 Wood units). Has WHO/NYHA-FC of II or III; On stable dose of at ...

  6. Visiting Medical Student Clerkships - Surgery, Oncology Subinternship (Florida)

    Absences should not be scheduled during the subinternship. Duration of rotation. One month. Dress. Appropriate Mayo Clinic dress for Outpatient Clinic ...

  7. Endoscopic Procedures Clinical Trials - Mayo Clinic Research

    The purpose of this study is determine if the metabolomic profile of nasal secretions can be used to reliably diagnose the presence or absence of sinusitis.

  8. Venetoclax In Combination With ASTX727 For The Treatment Of Chronic Myelomonocytic Leukemia And Other Myelodysplastic Syndrome/Myeloproliferative Neoplasm - Mayo Clinic

    to confirm the absence of brain metastases is not required. Patients with spinal cord compression unless considered to have received definitive treatment ...

  9. Phase 1/2 Dose Escalation and Efficacy Study of Anti-CD38 Monoclonal Antibody in Patients With Selected CD38+ Hematological Malignancies - Mayo Clinic

    ... absence of measurable m-protein, serum FLC ≥10 mg/dL, and abnormal serum immunoglobulin kappa lambda FLC ratio (<0.26 or >1.65). Patients must have ...

  10. A Multi-center Trial to Evaluate Multiple Regimens in Metastatic Pancreatic Cancer - Mayo Clinic

    ... absence of an external trigger are eligible to participate. - Receiving immunosuppressive or myelosuppressive medications that would, in the opinion of the ...